8 research outputs found
Treatment outcomes of previously-treated smear-positive TB patients, by INH resistance, registered under RNTCP in Gujarat, India, January-June 2013 (N = 3743).
<p>Treatment outcomes of previously-treated smear-positive TB patients, by INH resistance, registered under RNTCP in Gujarat, India, January-June 2013 (N = 3743).</p
Comparison of treatment outcomes across clinical and demographic factors of previously treated smear-positive TB patients registered in Gujarat from January-June 2013 (n = 5,829).
<p>Comparison of treatment outcomes across clinical and demographic factors of previously treated smear-positive TB patients registered in Gujarat from January-June 2013 (n = 5,829).</p
Baseline characteristics of previously-treated smear-positive TB patients, by DST status, registered under RNTCP in Gujarat, India, January-June 2013.
<p>Baseline characteristics of previously-treated smear-positive TB patients, by DST status, registered under RNTCP in Gujarat, India, January-June 2013.</p
Treatment outcomes of previously-treated smear-positive TB patients, by DST status, registered under RNTCP in Gujarat, India, January-June 2013.
<p>Treatment outcomes of previously-treated smear-positive TB patients, by DST status, registered under RNTCP in Gujarat, India, January-June 2013.</p
Effect of upfront Xpert MTB/RIF on rifampicin-resistant TB case detection.
<p>Effect of upfront Xpert MTB/RIF on rifampicin-resistant TB case detection.</p
Additional gain on Xpert MTB/RIF over smear microscopy-specimen wise analysis.
<p><i>*Others = Cervical Aspirate</i>, <i>Peritoneal Fluid</i>, <i>Tracheal aspirate</i>, <i>Abscess</i>, <i>Synovial Fluid</i>, <i>Bone</i>, <i>Chyle fluid</i>, <i>Nasal Aspirate</i>, <i>Pleural Biopsy</i>, <i>Thoracic swab</i>, <i>ET secretion</i>, <i>pericardial fluid</i>.</p><p>Additional gain on Xpert MTB/RIF over smear microscopy-specimen wise analysis.</p
Demographic profile of presumptive TB and DR-TB cases.
<p>Demographic profile of presumptive TB and DR-TB cases.</p